PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Integrative Computational Pharmacology and Data Mining, INSERM UMR 1141, NeuroDiderot, Robert-Debré Hospital, 75019 Paris, France.\', \'Sorbonne Université, INSERM 1136, Institut Pierre Louis d\'Epidémiologie et de Santé Publique, AP-HP, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de Virologie, F75013 Paris, France.\', \'Université de Bordeaux, INSERM, LAMC, U1029, F-33600 Pessac, France.\', \'Institut Bergonié, 33000 Bordeaux, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • 169510.3390/ijms22041695
?:doi
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 33567580
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all